article thumbnail

Limited funding hinders uptake of RPM, DTx in Australia

Healthcare IT News - Telehealth

Healthcare providers in Australia have been "slow" in their uptake of remote care technologies, such as remote patient monitoring and digital therapeutics. Practitioners are also unlikely to recommend remote care due to dearth of reimbursement incentives.

article thumbnail

HIMSS21 tech news: Salesforce Health Cloud innovations; Vivify telehealth scheduling

Healthcare IT News - Telehealth

"These new care from anywhere innovations ensure that we continue this digital transformation in healthcare and empower providers, payers, care coordinators and pharmaceutical companies to deliver care for patients wherever they are," he added. Vivify Health's remote care enhancements.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

AI-powered RPM boosts care for chronic conditions while saving costs

Healthcare IT News - Telehealth

We interviewed Nissim to discuss diabetes treatment challenges, how RPM can help overcome some of these challenges, how AI can boost RPM technology when dealing with chronic illnesses, how adequately addressing diabetes can save taxpayers money, and what Nissim calls "the next generation of remote care."

article thumbnail

2018 Year in Review: The Year’s Biggest Remote Care News & Developments

care innovations

As government agencies like the CMS and VA expanded access to telehealth towards the goal of extending care into rural areas, industry leaders like Care Innovations® announced a series of breakthroughs with exciting implications for the years to come. January: Unbundled CMS Code Increases Remote Care Reimbursement.

article thumbnail

A guide to connected health device and remote patient monitoring vendors

Healthcare IT News - Telehealth

Biofourmis’ digital therapeutics are used for RPM across three primary healthcare stakeholder groups: health systems, payers and pharmaceutical companies. Typically, the health systems and payers work together in a value-based care arrangement that involves shared risk and reward. Spry Health. Vivify Health.

article thumbnail

Average Multiples and Key Drivers of Digital Therapeutics (DTx) M&A deals in 2023

Lloyd Price

This is due to a number of factors, including: The increasing prevalence of chronic diseases The rising cost of healthcare The increasing demand for patient-centered care As a result, DTx companies are still expected to be attractive targets for M&A deals. The average deal size for DTx M&A deals is increasing.

article thumbnail

Where are HealthTech's soft landing M&A deals in today's market?

Lloyd Price

Traditional healthcare players: Hospitals, insurers, and pharmaceutical companies are increasingly acquiring healthtech startups to improve efficiency, patient engagement, and data-driven decision making. They might target smaller, innovative companies with niche solutions or complementary technologies at reasonable valuations.